$ASBP 8-K SEC Filings

Filed On	Filing
29 Sep 2026	8-K: Changes in Registrant's Certifying Accountant We have read Item 4.01 of Form 8-K dated September 24, 2026, of Aspire-Lakewood Holdings, Inc. (formerly, Aspire Biopharma Holdings, Inc.) and are in agreement with the statements insofar as they relate to our firm. We have no basis to a...
09 Sep 2026	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Other Events Reflects leadership’s view that Aspire-Lakewood’s share price does not reflect the Company’s financial strength or long-term growth opportunity
08 Sep 2026	8-K: Regulation FD Disclosure ASPIRE BIOPHARMA HOLDINGS, INC. ANNOUNCES CORPORATE NAME CHANGE TO ASPIRE-LAKEWOOD HOLDINGS, INC.
19 Aug 2026	8-K: Regulation FD Disclosure
10 Aug 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +2 more
20 Jul 2026	8-K: Other Events
22 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
12 Jun 2026	8-K: Other Events
12 Jun 2026	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
14 May 2026	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year
20 Apr 2026	8-K: Regulation FD Disclosure
16 Apr 2026	8-K: Entry into a Material Definitive Agreement; Amendments to Articles/Bylaws; Change in Fiscal Year
16 Apr 2026	8-K: Submission of Matters to a Vote of Security Holders
16 Apr 2026	8-K: Regulation FD Disclosure
15 Apr 2026	8-K: Entry into a Material Definitive Agreement
12 Feb 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +2 more
06 Feb 2026	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year
30 Jan 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities
15 Jan 2026	8-K: Departure/Election of Directors or Officers; Compensation
13 Jan 2026	8-K: Departure/Election of Directors or Officers; Compensation

Comments